SpringWorks Therapeutics (NASDAQ:SWTX) Receives Hold Rating from TD Cowen
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “hold” rating restated by analysts at TD Cowen in a report released on Tuesday, Marketbeat Ratings reports. They presently have a $47.00 price objective on the stock, down from their previous price objective of $66.00. TD Cowen’s price target would suggest a potential upside of […]
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “hold” rating restated by analysts at TD Cowen in a report released on Tuesday, Marketbeat Ratings reports. They presently have a $47.00 price objective on the stock, down from their previous price objective of $66.00. TD Cowen’s price target would suggest a potential upside of […]
